Structure Therapeutics American Stock Technical Analysis

GPCR Stock   35.60  0.28  0.78%   
As of the 17th of May 2024, Structure Therapeutics has the Variance of 14.19, coefficient of variation of (1,150), and Risk Adjusted Performance of (0.04). Structure Therapeutics technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down thirteen technical drivers for Structure Therapeutics American, which can be compared to its competition. Please validate Structure Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Structure Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 35.6 per share. Given that Structure Therapeutics has information ratio of (0.12), we advise you to double-check Structure Therapeutics American's current market performance to make sure the company can sustain itself at a future point.

Structure Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Structure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Structure
  
Structure Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Structure Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
83.17Strong Buy7Odds
Structure Therapeutics American current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Structure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Structure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Structure Therapeutics, talking to its executives and customers, or listening to Structure conference calls.
Structure Analyst Advice Details
Structure Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Structure Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Structure Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Structure Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fourty-eight with a total number of output elements of thirteen. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Structure Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Structure Therapeutics Trend Analysis

Use this graph to draw trend lines for Structure Therapeutics American. You can use it to identify possible trend reversals for Structure Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Structure Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Structure Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Structure Therapeutics American applied against its price change over selected period. The best fit line has a slop of   0.05  , which may suggest that Structure Therapeutics American market price will keep on failing further. It has 122 observation points and a regression sum of squares at 102.82, which is the sum of squared deviations for the predicted Structure Therapeutics price change compared to its average price change.

About Structure Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Structure Therapeutics American on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Structure Therapeutics American based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Structure Therapeutics price pattern first instead of the macroeconomic environment surrounding Structure Therapeutics. By analyzing Structure Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Structure Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Structure Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Current Ratio12.627.1619.1410.31
Net Debt To EBITDA2.781.721.221.85

Structure Therapeutics May 17, 2024 Technical Indicators

Most technical analysis of Structure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Structure from various momentum indicators to cycle indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Structure Therapeutics is a strong investment it is important to analyze Structure Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Structure Therapeutics' future performance. For an informed investment choice regarding Structure Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Structure Therapeutics information on this page should be used as a complementary analysis to other Structure Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Structure Stock analysis

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is Structure Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Structure Therapeutics. If investors know Structure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Structure Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.43)
Return On Assets
(0.22)
Return On Equity
(0.33)
The market value of Structure Therapeutics is measured differently than its book value, which is the value of Structure that is recorded on the company's balance sheet. Investors also form their own opinion of Structure Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Structure Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Structure Therapeutics' market value can be influenced by many factors that don't directly affect Structure Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Structure Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Structure Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Structure Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.